Natera Reports Largest Lung Cancer MRD Study for Signatera
AUSTIN, Texas — September 18, 2026 Natera announced new data from the IASLC 2026 World Conference on Lung Cancer...
Adjuvant Treatment
Advertisement
Caris Expands Precision Oncology Research With UNM Alliance
Irving, Texas, USA, August 8, 2026 Caris Life Sciences® announced that the University of New Mexico Comprehensive Cancer Center...
Neurocrine Advances Obesity Pipeline With NBIP-‘1968 Trial
San Diego, California, USA, August 8, 2026 Neurocrine Biosciences, Inc. has initiated a Phase 1 first-in-human clinical study evaluating...
Regeneron Expands Libtayo Approval for High-Risk CSCC
Toronto, Ontario, Canada, August 8, 2026 Regeneron Canada Company announced that Health Canada has approved Libtayo® (cemiplimab for injection)...
Advertisement
